Post-Scrip: The ASPL Pharmacy Law Podcast | S1E4 - Jay Warmuth, JD & Jane Blaney, JD - Faegre Drinker Biddle & Reath LLP
Listen now
Description
We're honored to have Jay Warmuth, JD & Jane Blaney, JD of Faegre Drinker Biddle & Reath LLP  to the program to give a preview into their conference presentation: "Developments in Laws and Regulations Impacting PBMs and Prescription Drug Access."  At the National Conference, this presentation will provide an overview of recent developments in PBM regulation and explore questions such as: Who are these laws and regulations designed to protect? What are the goals or objectives of the regulations? And are those objectives being achieved? They also will address a number of challenging legal issues that oftentimes arise in the context of these laws and regulations, including issues of federal statutory preemption and the cross-border application of certain state laws to multi-state or national health plan clients.  The 33rd annual American Society for Pharmacy Law Developments in Pharmacy Law seminar will be held November 3-6 at the Naples Grande Beach Resort in Naples, FL. The Seminar is being held in-person this year! Don't miss this opportunity to learn, share and network with seasoned legal and pharmaceutical professionals. Attendees will have the opportunity to earn up to 15 hours of ACPE and CLE continuing education credits. We look forward to having you join us in November!
More Episodes
In this episode of Post-Scrip, Henry introduces Jenni Wai, RPh. , MBA, Josh Bolin and Christopher R. Smith, JD, LLM. They discuss the upcoming "Regulatory, Industry and Legal Perspectives on the Future of the DSCSA".This presentation will provide an update on the final stages of implementation of...
Published 10/16/24
In this episode of Post-Scrip, Henry introduces Marty Allain, JD. They discuss the upcoming "How Drug Manufacturer Restrictions and Recent Court Decisions are Re-Shaping 340B Drug Distribution and Delivery Models".Pharmaceutical manufacturers continue to restrict the delivery of 340B drug...
Published 10/09/24